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a  b  s  t  r  a  c  t
Background:  Dislocation  is  a common  complication  of  total  hip  arthroplasty  (THA),  particularly  when
performed  as  revision  surgery.  Dual  mobility  cups  (DMCs)  minimize  the  risk  of  instability  when  implanted
during primary  THA.  However,  their  usefulness  and  survival  in  revision  THA  remain  unclear.  We  therefore
conducted  a retrospective  study  to  assess  DMC  stability  and  survival  at a  minimal  follow-up  period  of
5 years  after revision  THA.
Hypothesis:  The  dislocation  rate  associated  with  DMCs  for  revision  THA  is  similar  to that  seen after
primary  THA.
Materials and methods:  Cup  exchange  with  implantation  of a DMC  was performed  in 71  patients  (74
hips)  between  2000  and  2007,  for the  following  reasons:  recurrent  dislocation  (n =  22), aseptic  loosening
(n  =  38),  and  infection  (n  = 14).  The  DMCs  were  cemented  in 47  cases  and  cementless  in 27  cases.  The
clinical  variables  (Merle  d’Aubigné-Postel  score  and  Harris  Hip Score)  and  radiological  ﬁndings  were
collected  retrospectively  from  the  medical  records  and  compared  with  those  obtained  at the  last  follow-
up  visit.
Results:  Of  the  74  cases,  2 were  lost  to follow-up.  At last  follow-up,  the  mean  Merle  d’Aubigné-Postel
score  was  15.2 (11–18)  and  the  mean  Harris  Hip  Score  was  80.4 (51–98).  Of the  8  failures,  2 (2/72,  2.7%)
were  related  to  mechanical  factors  (1 case  each  of  aseptic  loosening  and dislocation)  and 6 were  changed
because  of  infection  (recurrent  infection,  n  = 4). Mechanical  failure  was not  linked  to a speciﬁc  reason  for
revision  THA.  A radiolucent  line  was  visible  in  4 cases  but this  ﬁnding  was  not  associated  with  clinical
manifestations.  When  failure  was  deﬁned  as  cup  revision  for  any  non-infectious  complication,  5-year
implant  survival  was 99% (95%  conﬁdence  interval,  93–100%).
Discussion:  Use  of  a DMC  in  revision  THA  was  associated  with  a slightly  higher  dislocation  rate  (1/72,  1.4%)
than in primary  THA,  whereas  5-year  survival  was  comparable.  Cemented  DMCs  were  not  associated  with
a  greater  risk  of  loosening.
Conclusion: DMCs  are  useful  to decrease  the risk  of  dislocation  in revision  THA  performed  for any  reason.
The  low  rate  of  loosening  indicates  that DMCs  do  not  result  in  high  stresses  at the  bone-implant  interface.
Level  of evidence:  IV,  retrospective  study.
©  2015  Published  by Elsevier  Masson  SAS.. Introduction
The dual mobility cups (DMC) designed by Gilles Bousquet are
sed in an expanding range of indications. This implant has been
emonstrated to improve hip stability in primary total hip arthro-
lasty (THA) [1–7] and recurrent hip dislocation after THA [8–12].
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877-0568/© 2015 Published by Elsevier Masson SAS.Less is known about DMC  outcomes in revision THAs performed
for reasons other than recurrent dislocation [13–17], although
these procedures carry a high risk of postoperative hip instability
[18,19]. Other implant designs, such as the retentive cup and the
large-diameter femoral head, decrease the risk of hip instability but
are often associated with high rates of wear and loosening [20,21].
We therefore conducted a retrospective study to determine
whether:• DMCs used for revision surgery were associated with similar dis-
location rates to those seen with DMCs for primary THA;
• DMC  survival after revision surgery.

















































74 inc luded cases
(71 p aents)
72 cases analy sed
(69 p aents)
2 cases lost to fol low -
up
(2 paents)
10 paents died, none 
was re-op erated
(11 cases)
Cup in pla ce
51 paents  eva luated 
aer more than 5 
years
(53 case s)
Cup in pla ce
8 fail ures
(8 paents)
- 1 mechanical  fa ilure
- 1 instability
- 2 infecons
- 4 recurre nt infe cons 78 E. Simian et al. / Orthopaedics & Traumat
We  hypothesised that dislocation rates with DMCs were similar
fter primary and revision THA.
. Materials and methods
.1. Patients
The inclusion criteria were implantation of a DMC  during cup
xchange surgery and a follow-up of at least 5 years. Starting in the
000s, growing interest in DMCs prompted us to use this cup design
or revision THA. Between 2000 and 2007, 74 DMCs were implanted
or cup exchange in 71 patients. During the same period, cup
xchange was performed with other cup designs in 114 patients.
he reasons for choosing a DMC  were older age and risk factors for
ip instability (i.e., multiple revisions or revision for hip instability
r infection). The reasons for cup exchange were recurrent dis-
ocation (n = 22), aseptic dislocation (n = 38), and infection (n = 14,
ith one-stage procedure in 11 cases and two-stage procedure in
 cases).
The 44 females and 27 males had a mean age of 67.9 ± 9.3 years
range, 38–90) at revision surgery. In 2 females, aseptic loosening
equired bilateral cup exchange. Another female underwent bilat-
ral cup exchange, for recurrent dislocation on the right side and
septic loosening on the left side.
.2. Methods
Three DMC designs were used: DMSTM (cobalt-chromium,
emented; SEM, Paris, France) in 47 cases, EvoraTM (cobalt-
hromium coated with hydroxyapatite coating, cementless; SEM)
n 23 cases, and revision MobilitéTM (coated with hydroxyap-
tite, cementless; Tornier, Saint-Ismier, France) in 4 cases. In
atients with good-quality bone after reaming and without bony
efects, a cementless implant was used (n = 27). Poor bone quality
equired a cemented implant in 47 cases, including 23 in which
he presence of a bony defect prompted the use of a GanzTM
einforcement Ring (Zimmer, Warsaw, IN, USA) and defect ﬁlling
ith allogeneic bone. The postero-lateral approach was used in all
4 cases.
.3. Outcome assessment methods
The clinical data (Postel-Merle d’Aubigné [PMA] [22] score and
arris Hip Score [23]) and radiological ﬁndings were collected ret-
ospectively from the medical records and compared with those
btained at last follow-up visit. The set of radiographs consisted
f an antero-posterior view of the pelvis and antero-posterior and
ateral views of the operated hip. Granuloma-related osteolysis and
adiolucent lines in the acetabulum were evaluated on serial radio-
raphs in the DeLee and Charnley zones [24]. Loosening was deﬁned
s more than 3◦ of change in the cup inclination angle or more than
 mm of cup migration [9].
.4. Statistical methods
Kaplan–Meier survival curves were plotted with the 95% con-
dence intervals (95% CIs), using StatView 3.0 (Abacus Concepts,
erkeley, CA, USA) and R 2.10.1 (R Foundation for Statistical Com-
uting, Vienna, Austria). The Kaplan–Meier method was applied to
nalyse survival, using two deﬁnitions of failure, i.e., surgical cup
evision for any reason and surgical cup revision for non-infectious
easons. The survival analysis included computation of the 95% CIs,
ntil the interval including at least 30 study cases.Fig. 1. Patient ﬂow chart.
3. Results
Of the 71 patients (74 hips), 51 (53 hips) were re-evaluated.
Mean follow-up in these 53 cases was 87.6 months (range,
60–137 months). Only 2 patients (2.7%) were lost to follow-up;
both still had their DMC  at last follow-up after 15 and 41.5 months,
respectively. In addition, 10 patients (11 hips) died, at a mean of
38 months (range, 6–80 months) after revision surgery, without
any instances of re-operation or dislocation.
Of the 72 assessable cases, 8 underwent removal of the DMC.
In 6 (8.3%) cases, DMC  removal was  required because of infection
(recurrent infection, n = 4) after a mean follow-up of 15.7 months
(1–55 months). In the 2 (2.7%) remaining cases, the reason for DMC
removal was  mechanical: aseptic loosening in 1 (1.4%) case, after
117 months; and dislocation of the large joint in 1 (1.4%) case,
requiring reduction by external manoeuvres under general anaes-
thesia 10.5 months after cup exchange for hip instability. No links
were obvious between these failures and any of the three cup
designs used. No patients experienced intra-prosthetic dislocation.
Of the 51 patients (53 hips) with no cup exchange during a
follow-up of at least 5 years, 8 (8 hips) were not re-evaluated clini-
cally and had no follow-up radiographs after at least 5 years (Fig. 1).
Thus, 43 patients (45 hips) were evaluated. The mean PMA  score
was 15.2 ± 2 (11–18) and the mean HHS was  80.4 ± 12.9 (51–98)
(Table 1). Mean cup inclination in the coronal plane was 44.6◦
(38◦–54◦). There were no radiolucent lines in 40 cases, including
all 23 cases managed with a GanzTM Reinforcement Ring (which
consistently produced strong ﬁxation). A continuous 2-mm radi-
olucent line was visible in each of 4 asymptomatic patients. In 2
of these cases (MobilitéTM and DMSTM in 1 case each), the line
remained stable over time and was  associated with osteolysis in
zones 1 and 3 or in zones 1, 2, and 3, respectively. Progression of
the line was documented in the other 2 cases (DMSTM in both),
which were associated with osteolysis in zones 1 and 2 or in zones
2 and 3, respectively. In a 60-year-old woman who  was asymp-
tomatic (PMA = 18; and HHS = 98), migration over more than 3 mm
was noted 123 months after EvoraTM cup implantation, as well as
polyethylene wear and acetabular osteolysis in zones 1, 2, and 3.
When failure was  deﬁned as revision surgery for any reason, the
5-year implant survival rate was  90% (95% CI, 84–95%) (Fig. 2). A
major reason for failure was infection (n = 6, 8.3%), a complication
not directly related to the implant. When failure was deﬁned as
revision for non-infectious reasons, 5-year implant survival was
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Table  1
Outcomes according to implant design and reason for revision surgery.
Indication Aseptic loosening Dislocation Infection
Cup Cemented Cementless Cemented Cementless Cemented Cementless
Number of cases 18 8 8 6 3 2
PMA  score [22] 14.5 (11–18) 15.0 (12–18) 14.5 (12–16) 16.8 (15–18) 16.7 (16–17) 17.0 (16–18)
Harris Hip Score [23] 76.0 (51–96) 81.1 (67–98) 75.4 (59–92) 91.0 (84–94) 88.3 (83–96) 89.0 (87–91)
Progressive radiolucency 2 cases
Stable radiolucency 1 case 1 case


























oig. 2. Implant survival curve obtained when failure was deﬁned as cup revision for
ny reason.
9% (95% CI, 93–100%) (Fig. 3). The marked decrease in numbers
f exposed patients over time precluded a meaningful analysis of
urvival rates after longer follow-up (only 28 cases with data after
 years).
. Discussion
The outcomes were satisfactory, with a single case of dislocation,
roducing a rate of 1.4%. This value is similar to rates reported after
MC use for revision THA [8–17], but higher than those reported
ith DMCs for primary THA [1–7]. When failure was  deﬁned as
evision for non-infectious complications, 5-year survival was 99%
95% CI, 93–100%), i.e., comparable to previously reported rates of
MC  survival in primary and revision THA (Table 2).
This study has several limitations. First, the patient population
as heterogeneous. However, our goal was to assess DMC  disloca-
ion rates after revision surgery for any reason and with any implant
esign, since the underlying principles are always the same. Second,
he age of the patients and occurrence of infectious complications
xplain that only 71% of patients were re-evaluated after more
han 5 years, whereas outcome data were available for 97.3% of
he implants. Third, the 5-year follow-up may  seem insufﬁcient,
lthough it should be kept in mind that a substantial proportion of
omplications develop within the ﬁrst 3 years [2]. Fourth, interpre-
ation of the standard radiographs was often difﬁcult, particularly
n patients with cemented DMCs in a reinforcement ring. Therefore,
ur data on cup ﬁxation should be interpreted with caution.Fig. 3. Implant survival curve obtained when failure was deﬁned as cup revision for
non-infectious complications.
Instability is among the main complications of prosthetic revi-
sion surgery [18,19,25]. The dislocation rate in our study (1.4%, 1
case) is comparable to the rates found in other studies of DMC  use
for revision THA [8–17]. Garbuz et al. [26] reported beneﬁts from
using large-diameter heads (36 and 40 mm)  to prevent instability
in exchange THA, but they have the major drawback of inducing
marked polyethylene wear [20]. The risk of wear is lower with
DMCs, as reported by Adam et al. [27] and, more recently, by Prud-
hon et al. [28]. Several studies demonstrated lower loosening rates
with DMCs than with retentive cups [9,10,15]. The low disloca-
tion rate supports our policy of using DMCs almost routinely for
exchange THA. However, the dislocation rate was higher than for
primary THA [1–7], a situation in which dislocation rates after DMC
implantation are consistently lower than 1% and sometimes nil.
Numerous factors inﬂuence the stability of a total hip prosthesis,
including implant positioning, the number of previous surgical pro-
cedures, whether synovectomy is performed, and the presence of
muscle damage related to iterative dissection. These risk factors
for dislocation are more common in patients undergoing revision
compared to primary THA.
Cemented metal cups are associated with high rates of loos-
ening and polyethylene wear [29,30]. In our study, no cases of
loosening occurred in the subgroup managed with a cemented
TMDMC  and a Ganz reinforcement ring. On the other hand, in 2
hips a DMC  cemented onto the bone was surrounded by a radi-
olucent line, indicating a need for close monitoring. Other studies






















Previously reported outcomes of dual mobility cups.










Cup inclination AL Survival rate
Primary THA
Philippot et al. [3] Primary THA Cementless 106 12 1 (0.9%) 10 years 15.8 ± 0.8 0 2 46.8◦ 2 94.6% (10 years)
Leclercq  et al. [5] Primary THA Cementless 200 56 31 (15.5%) 11 years 16.3 0 0 46◦ 0 99% (10 years)
Combes  et al. [7] Primary THA Cementless 3474 470 524 (15.1%) 7 years 15 7 31 93% (10 years)
Revision  THA
Hamadouche et al. [9] Dislocation Cemented 51 2 1 (1.9%) 51.4 months 15.8 ± 2.2 1 1 47◦ 1 95.7% (72 months)
Leiber-Wackenheim et al. [10] Dislocation Cementless 59 9 0 8 years 16.5 1 0 0 98% (8 years)
Mertl  et al. [11] Dislocation Cemented or
cementless
180 21 14 (7.7%) 7.7 years 15.7 ± 2.5 7 2 2 92.6% (8 years)
Langlais  et al. [15] AL Cemented 88 3 0 3 years 16.1 0 1 2 94.6% (5 years)
Massin  et al. [16] AL and dislocation Cementless 23 0 0 4.5 years 15 2 0 0




Cemented 96 15 4 (4.2%) 41 months 15.5 ± 2.3 11 0 2 95.6% (8 years)




74 11 2 (2.7%) 7.3 years 15.2 1 0 44.6◦ 2 99% (5 years)







































with  metal-backed ace tabular components. 124 cases with 21 months follow-E. Simian et al. / Orthopaedics & Traumat
r implanted in a GanzTM Reinforcement Ring [17], a fact that may
eﬂect decreased stresses at the cement-bone interface. Delayed
obilisation occurred for 2 cementless DMCs, of which 1 did not
equire re-operation. In this last case, polyethylene wear respon-
ible for granuloma formation is a possibility. In case-series of
ementless DMCs for primary THA, success rates were satisfactory
93% after 10 years according to Combes et al. [7] and 99% after
0 years according to Leclercq et al. [5]). Similarly, satisfactory out-
omes were obtained with press-ﬁt DMCs used for revision THA
98% after 8 years for Leiber-Wackenheim et al. [10]).
. Conclusion
The results of this case-series study conﬁrm the usefulness of
MCs for revision THA, in particular when the cup is maintained in
 reinforcement ring.
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